Polydrug use, cannabis, and psychosis-like symptoms

Human Psychopharmacology

Volumn 23, Issue 6, 2008, Pages 475-485

  Van Dam, Nicholas T ^a   Earleywine, Mitch ^a   DiGiacomo, Greg ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cannabis; Psychosis; Schizotypal Personality Questionnaire; Schizotypy

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; DIAMORPHINE; DRUG; ILLICIT DRUG; METHAMPHETAMINE;

ADULT; ARTICLE; CANNABIS ADDICTION; FEMALE; HUMAN; LEGAL ASPECT; MAJOR CLINICAL STUDY; MALE; MULTIPLE DRUG ABUSE; PRIORITY JOURNAL; PSYCHOSIS; QUESTIONNAIRE; SCHIZOTYPAL PERSONALITY DISORDER; SYMPTOM;

ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PSYCHOSES, SUBSTANCE-INDUCED; QUESTIONNAIRES; SCHIZOTYPAL PERSONALITY DISORDER;

EID: 51049107431     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.950     Document Type: Article

References (56)

1. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders, 4th Edn, Text Revision. American Psychiatric Association: Washington, DC.
2. Arsenault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. 2002. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325: 1212-1213.
3. Arsenault L, Cannon M, Witton J, Murray RM. 2004. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184: 110-117.
4. Bailey EL, Swallow BL. 2004. The relationship between cannabis use and schizotypal symptoms. Eur Psychiatry 19: 113-114.
5. Barkus EJ, Stirling J, Hopkins RS, Lewis S. 2006. Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology 39: 175-178.
6. Bedi G, Redman J. 2008. Metamemory in recreational ecstasy polydrug users: what do self-reports of memory failures mean? J Psychopharmacol DOI: 10.1177/0269881107083811.
7. Berry N, Jobanputra V, Pal H. 2003. Molecular genetics of schizophrenia: a critical review. J Psychiatry Neurosci 28(6): 415-429.
8. Callow N. 1996. Use of snowballing technique to investigate subjective mood and personality traits associated with 'Ecstasy'. Proc Br Psychol Soc 5: 49.
9. Cohen J. 1994. The earth is round (p < .05). Am Psychol 49(12): 997-1003.
10. Colado MI, O'Shea E, Green AR. 2004. Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology 173: 249-263.
11. Cole JC, Sumnall HR. 2003. Altered states: the clinical effects of ecstasy. Pharmacol Ther 98(1): 35-58.
12. Dumas P, Saoud M, Bouafia S, et al. 2002. Cannabis use correlates with schizotypal personality traits in healthy students. Psychiatry Res 109: 27-35.
13. Earleywine M. 2002. Understanding Marijuana. Oxford University Press: New York.
14. Everitt BJ, Wolf ME. 2002. Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 22(9): 3312-3320.
15. Fenton WS, McGlashan TH. 1989. Risk of schizophrenia in character disordered patients. Am J Psychiatry 146(10): 1280-1284.
16. Gardner EL. 2005. Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol Biochem Behav 81: 263-284.
17. Hall W. 2006. Is cannabis use psychotogenic? Lancet 367: 193-195.
18. Hall W, Degenhardt L, Teeson M. 2004. Cannabis use and psychotic disorders: an update. Drug Alcohol Rev 23(4): 433-443.
19. Henquet C, Krabbendam L, Spauwen J, et al. 2005. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 330: 11.
20. Johns A. 2001. Psychiatric effects of cannabis. Br J Psychiatry 178: 116-122.
21. Larrison AL, Briand KA, Sereno AB. 1999. Nicotine, caffeine, alcohol, and schizotypy. Pers Individ Dif 27: 101-108.
22. Livesley WJ. 2001. Conceptual and taxonomic issues. In Handbook of Personality Disorders, WJ Livesley (ed). Guilford: New York; 3-38.
23. Macleod J, Smith GD, Hickman M, Egger M. 2007. Cannabis and psychosis. Lancet 370: 1539.
24. Mass R, Bardong C, Kindl K, Dahme B. 2001. Relationship between cannabis use, schizotypal traits, and cognitive function in healthy subjects. Psychopathology 34: 209-2214.
25. Mata I, Mataix-Cols D, Peralta V. 2005. Schizotypal personality questionnaire-brief: factor structure and influence of sex and age in a nonclinical population. Pers Individ Dif 38(5): 1183-1192.
26. Meehl PE. 1990. Toward an integrated theory of schizotaxia, schizotypy, and schizophrenia. J Personal Disord 4: 1-99.
27. Milani RM, Parrott AC, Schifano F, Turner JJD. 2005. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms. Hum Psychopharmacol Clin Exp 20: 249-261.
28. Moore THM, Zammit S, Lingford-Hughes A, et al. 2007. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370: 319-328.
29. Mullen MK. 1994. Earliest recollections of childhood: a demographic analysis. Cognition 52: 55-79.
30. Nunn JA, Rizza F, Peters ER. 2001. The incidence of schizotypy among cannabis and alcohol users. J Nerv Ment Dis 189: 741-748.
31. Parrott AC. 2004. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacology 173: 234-241.
32. Parrott AC, Milani RM, Parmar R, Turner JJD. 2001. Recreational ecstasy/ MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems. Psychopharmacology 159: 77-82.
33. Raine A. 1991. The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull 17: 555-564.
34. Raine A. 2006. Schizotypal personality: neurodevelopmental and psychosocial trajectories. Annu Rev Clin Psychol 2: 291-326.
35. Raine A, Benishay D. 1995. The SPQ-B: a brief screening instrument for schizotypal personality disorder. J Personal Disord 9(4): 346-355.
36. Reips U-D. 2002. Standards for internet-based experimenting. Exp Psychol 49(4): 243-256.
37. Reynolds C, Raine A, Mellingen K, Venables P, Mednick S. 2001. Three-factor model of schizotypal personality: invariance across culture, gender, religious affiliation, family adversity, and psychopathology. Schizophr Bull 26(3): 603-618.
38. Rhodes S, Bowie D, Hergenrather K. 2003. Collecting behavioural data using the world wide web: considerations for researchers. J Epidemiol Community Health 57: 68-73.
39. Robbins TW, Everitt BJ. 1999. Drug addiction: bad habits add up. Nature 398: 567-570.
40. Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrot A. 2001. Differential effects of ecstasy and cannabis on self-reports of memory ability: a web-based study. Hum Psychopharmacol Clin Exp 16: 619-626.
41. Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott AC. 2003. Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study. J Psychopharmacol 17(4): 389-396.
42. Schiffman J, Nakamura B, Earleywine M, LaBrie J. 2005. Symptoms of schizotypy precede cannabis use. Psychiatry Res 134: 37-42.
43. Schuckit MA. 2006. Comorbidity between substance use disorders and psychiatric conditions. Addiction 101 (Suppl 1): 76-88.
44. Siever LJ. 1995. Brain structure/function and the dopamine system in schizotypal personality disorder. In Schizotypal Personality Disorder, Raine A, Lencz T, Mednick SA (eds). Cambridge University Press: Cambridge; 272-288.
45. Skosnik P, Spatz-Glenn L, Park S. 2001. Cannabis use is associated with schizotypy and attentional disinhibition. Schizophr Res 48: 83-92.
46. Smit F, Bolier L, Cuijpers P. 2004. Cannabis use and the risk of later schizophrenia: a review. Addiction 99: 425-430.
47. van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H. 2002. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 156(4): 319-327.
48. Verdoux H, Sorbara F, Gindre C, Swendsen JD, van Os J. 2002. Cannabis use and dimensions of psychosis in a nonclinical population of female subjects. Schizophr Res 59: 77-84.
49. Volkow ND. 2005. What do we know about drug addiction? Am J Psychiatry 162(8): 1401-1402.
50. Vollema MG, Hoijtink H. 2000. The multidimensionality of self-report schizotypy in a psychiatric population: an analysis using multidimensional Rasch models. Schizophr Bull 26(3): 565-575.
51. Vollema MG, Sitskoorn MM, Appels MCM, Kahn RS. 2002. Does the schizotypal personality questionnaire reflect the biological-genetic vulnerability to schizophrenia? Schizophr Res 54: 39-45.
52. Wang Y, Lee C, Lew-Ting C, Hsiao C, Duan-Rung C, Chen W, 2005. Survery of substance use among high school students in Taipei: web-based questionnaire versus paper-and-pencil questionnaire. J Adolesc Health 37: 289-295.
53. Williams JH, Wellman NA, Rawlins JNP. 1996. Cannabis use correlates with schizotypy in healthy people. Addiction 91(6): 869-877.
54. Yung AR, Phillips LJ, Yen HP, et al. 2003. Psychosis prediction: 12-month follow-up of a high-risk ("prodromal") group. Schizophr Res 60(1): 21-32.
55. Zammit S, Moore T, Lewis G. 2007. Cannabis and psychosis: authors' reply. Lancet 370: 1539-1540.
56. Zullino DF, Rathelot T, Khazaal Y. 2007. Cannabis and psychosis. Lancet 370: 1540.